InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: lasers post# 150873

Saturday, 04/11/2015 11:57:30 PM

Saturday, April 11, 2015 11:57:30 PM

Post# of 404311
Lasers, will Plaintiff discuss Elite's superior ADF tech?


Seems like timing will be terrible for Purdue. Just about the time this case comes to trial, FDA will be approving Elite's 2nd ADF-opioid, 12 hour oxycodone, with equivalent efficacy to OxyContin and immaculate HAL data. Plaintiff's attorney will have a great time questioning Purdue about why they let their exclusive license to Elite's well-proven ADF lapse back in 2004. Took them until 2010 to release their easily-defeated hardshell ADF. Hundreds of thousands of addicts and thousands of deaths during that time period.

Purdue's got some 'splaining to do, and I question whether they will really want to have to also explain why they're suing Elite to keep superior pharmacology-based ADF off the market, especially if the HAL data shows superiority over hardshell OxyContin.

I have no idea whether these suits against Purdue will be successful, but I do believe they will have an effect on Purdue's litigiousness. I understand their prior history of "Sue 'em all and ask questions later," but their special relationship with Elite's ADF, dating back more than 10 years, just may be an Achilles Heel that they'd rather not expose of their own free will.

I predict Purdue will not sue Elite.

"There are three kinds of lies: lies, damned lies, and statistics."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News